The Epidemic of Non–Hodgkin Lymphoma in the United States: Disentangling the Effect of HIV, 1992–2009
- 1 June 2013
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 22 (6) , 1069-1078
Abstract
Background: For decades, non–Hodgkin lymphoma (NHL) incidence has been increasing worldwide. NHL risk is strongly increased among HIV-infected people. Our understanding of trends in NHL incidence has been hampered by difficulties in separating HIV-infected NHL cases from general population rates. Methods: NHL incidence data during 1992–2009 were derived from 10 U.S. SEER cancer registries with information on HIV status at NHL diagnosis. The CDC estimated the number of people living with HIV in the registry areas. The proportion of NHL cases with HIV and NHL rates in the total and the HIV-uninfected populations were estimated. Time trends were assessed with Joinpoint analyses. Results: Of 115,643 NHL cases diagnosed during 1992–2009, 5.9% were HIV-infected. The proportions of NHL cases with HIV were highest for diffuse large B-cell (DLBCL; 7.8%), Burkitt (26.9%), and peripheral T-cell lymphomas (3.2%) with low proportions (≤1.1%) in the other subtypes. NHL rates in the total population increased 0.3% per year during 1992–2009. However, rates of NHL in HIV-uninfected people increased 1.4% per year during 1992–2003, before becoming stable through 2009. Similar trends were observed for DLBCLs and follicular lymphoma in HIV-uninfected people; rates increased 2.7% per year until 2003 and 1.7% per year until 2005, respectively, before stabilizing. Conclusions: NHL incidence rates in the United States have plateaued over the last 5–10 years, independent of HIV infection. Impact: Although the causes of the long-term increase in NHL incidence rates in the United States remain unknown, general population rates of NHL have stabilized since the early 2000s, independent of HIV. Cancer Epidemiol Biomarkers Prev; 22(6); 1069–78. ©2013 AACR.Keywords
All Related Versions
This publication has 30 references indexed in Scilit:
- Cancer Burden in the HIV-Infected Population in the United StatesJNCI: Journal of the National Cancer Institute, 2011
- Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989–2007Annals of Oncology, 2011
- Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous SystemJNCI: Journal of the National Cancer Institute, 2011
- Age-period-cohort modelling of non-Hodgkin's lymphoma incidence in a French region: a period effect compatible with an environmental exposureEnvironmental Health, 2010
- Attenuation of the epidemic increase in non-Hodgkin's lymphomas in SpainAnnals of Oncology, 2010
- Etiologic heterogeneity among non-Hodgkin lymphoma subtypesBlood, 2008
- Incidence and mortality from non‐Hodgkin lymphoma in Europe: The end of an epidemic?International Journal of Cancer, 2008
- Effect of HAART on Incident Cancer and Noncancer AIDS Events Among Male HIV SeroconvertersJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)Blood, 2007
- Incidence of Non-Hodgkin's Lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an Epidemic That WasCancer Epidemiology, Biomarkers & Prevention, 2006